Shanghai Runda Med Tech Co (603108) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) has a cash flow conversion efficiency ratio of 0.028x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥144.38 Million ≈ $21.13 Million USD) by net assets (CN¥5.15 Billion ≈ $752.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603108 company net worth for the company's overall valuation and market capitalisation.
Shanghai Runda Med Tech Co - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Shanghai Runda Med Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Runda Med Tech Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Runda Med Tech Co ranked by their cash flow conversion efficiency. Explore 603108 cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fujian Longma Envi Sanitation
SHG:603686
|
0.030x |
|
Mako Mining Corp Common Stock
NASDAQ:MAKO
|
0.137x |
|
Orient Semiconductor Electronics Ltd
TW:2329
|
0.023x |
|
Sonaecom SGPS
LS:SNC
|
-0.002x |
|
Shenzhen Farben Information Technology Co.Ltd.
SHE:300925
|
N/A |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
0.006x |
|
Magazine Luiza S.A
SA:MGLU3
|
0.459x |
|
Shenzhen Riland Industry Co
SHE:300154
|
0.062x |
Annual Cash Flow Conversion Efficiency for Shanghai Runda Med Tech Co (2014–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Runda Med Tech Co from 2014 to 2024. View 603108 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.60 Billion ≈ $820.06 Million |
CN¥646.95 Million ≈ $94.67 Million |
0.115x | -13.83% |
| 2023-12-31 | CN¥5.45 Billion ≈ $797.10 Million |
CN¥729.72 Million ≈ $106.78 Million |
0.134x | +256.49% |
| 2022-12-31 | CN¥5.01 Billion ≈ $733.10 Million |
CN¥-428.86 Million ≈ $-62.76 Million |
-0.086x | -201.31% |
| 2021-12-31 | CN¥4.39 Billion ≈ $642.69 Million |
CN¥371.11 Million ≈ $54.31 Million |
0.084x | +6.59% |
| 2020-12-31 | CN¥4.08 Billion ≈ $597.07 Million |
CN¥323.44 Million ≈ $47.33 Million |
0.079x | +13.00% |
| 2019-12-31 | CN¥3.52 Billion ≈ $514.56 Million |
CN¥246.68 Million ≈ $36.10 Million |
0.070x | -59.24% |
| 2018-12-31 | CN¥3.13 Billion ≈ $458.14 Million |
CN¥538.90 Million ≈ $78.86 Million |
0.172x | +638.52% |
| 2017-12-31 | CN¥2.75 Billion ≈ $402.20 Million |
CN¥-87.85 Million ≈ $-12.86 Million |
-0.032x | +43.39% |
| 2016-12-31 | CN¥2.22 Billion ≈ $325.17 Million |
CN¥-125.47 Million ≈ $-18.36 Million |
-0.056x | +76.87% |
| 2015-12-31 | CN¥928.55 Million ≈ $135.88 Million |
CN¥-226.69 Million ≈ $-33.17 Million |
-0.244x | -421.52% |
| 2014-12-31 | CN¥475.63 Million ≈ $69.60 Million |
CN¥36.11 Million ≈ $5.28 Million |
0.076x | -- |
About Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more